author-photo

Elias J. Jabbour

University of Texas at Austin

34

Papers

71

Citations

Citation Trend

Filter By

Papers (25) Sort By

Journal Conference Others

Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes after Third Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Acute and Chronic Leukemias

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes By Treatment Setting and Genomic Profile in Patients with AML on Cladribine, Idarubicin, and Cytarabine

2017 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Persistent Somatic Mutation at Remission Is Associated with Poor Survival and Higher Risk of Relapse in Patients with Acute Myeloid Leukemia

2017 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Blinatumomab in B-Cell Acute Lymphoblastic Leukemia with Positive Minimal Residual Disease: Initial Results of a Phase II Trial

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A Randomized Phase II Trial of 5-Day Versus 10-Day Schedules of Decitabine for Older Patients with Previously Untreated Acute Myeloid Leukemia

2017 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Survival Outcome of Secondary Solid Cancer in Patients with Chronic Myeloid Leukemia

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Characteristics and Outcomes of Malignancy-Associated Hemophagocytic Lymphohistiocytosis (HLH) in Adults: A Single-Center Experience

2017 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Hyper-CVAD Plus Ofatumumab As Frontline Therapy in CD20+ Acute Lymphoblastic Leukemia: Updated Results of a Phase II Trial

2017 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Impact of Earlier Vs. Later Monitoring on Disease Progression and Economic Outcomes Among Patients with Chronic Myeloid Leukemia in the Real-World Setting

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)